Tumour-necrosis-factor antibody treatment in Crohn's disease

Lancet. 1993 Jul 17;342(8864):173-4. doi: 10.1016/0140-6736(93)91375-v.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aminosalicylic Acids / therapeutic use
  • Antibodies, Monoclonal / therapeutic use*
  • Azathioprine / therapeutic use
  • Child
  • Crohn Disease / drug therapy
  • Crohn Disease / immunology
  • Crohn Disease / therapy*
  • Female
  • Humans
  • Mesalamine
  • Prednisone / therapeutic use
  • Tumor Necrosis Factor-alpha / immunology*

Substances

  • Aminosalicylic Acids
  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Mesalamine
  • Azathioprine
  • Prednisone